A new trading day began on Friday, with Chimerix Inc (NASDAQ: CMRX) stock price remained unchanged from the previous day of trading, before settling in for the closing price of $8.43. CMRX’s price has ranged from $0.75 to $8.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 347.46% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -6.24%. With a float of $78.69 million, this company’s outstanding shares have now reached $89.94 million.
In an organization with 72 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -13286.16%, operating margin of -58380.5%, and the pretax margin is -52574.84%.
Chimerix Inc (CMRX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Chimerix Inc is 15.43%, while institutional ownership is 44.93%. The most recent insider transaction that took place on Feb 13 ’25, was worth 13,799. In this transaction CHIEF MEDICAL OFFICER of this company sold 3,065 shares at a rate of $4.50, taking the stock ownership to the 152,875 shares. Before that another transaction happened on Feb 13 ’25, when Company’s PRESIDENT AND CEO sold 7,370 for $4.52, making the entire transaction worth $33,282. This insider now owns 609,603 shares in total.
Chimerix Inc (CMRX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.30% during the next five years compared to 8.31% growth over the previous five years of trading.
Chimerix Inc (NASDAQ: CMRX) Trading Performance Indicators
Here are Chimerix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4902.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.16 in one year’s time.
Technical Analysis of Chimerix Inc (CMRX)
Let’s dig in a bit further. During the last 5-days, its volume was 28.57 million. That was better than the volume of 4.72 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 99.24%. Additionally, its Average True Range was 0.52.
During the past 100 days, Chimerix Inc’s (CMRX) raw stochastic average was set at 99.48%, which indicates a significant increase from 98.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 225.33% in the past 14 days, which was higher than the 208.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.31, while its 200-day Moving Average is $1.84. However, in the short run, Chimerix Inc’s stock first resistance to watch stands at $8.44. Second resistance stands at $8.45. The third major resistance level sits at $8.47. If the price goes on to break the first support level at $8.42, it is likely to go to the next support level at $8.40. The third support level lies at $8.39 if the price breaches the second support level.
Chimerix Inc (NASDAQ: CMRX) Key Stats
With a market capitalization of 784.39 million, the company has a total of 89,936K Shares Outstanding. Currently, annual sales are 320 K while annual income is -82,100 K. The company’s previous quarter sales were 30 K while its latest quarter income was -22,880 K.
